Form 4: Entrada Therapeutics Director Gina Chapman Acquires Stock Options
SEC Form 4 Filing
Director Gina Chapman acquired stock options for 16,000 shares of Entrada Therapeutics common stock on June 13, 2024.
Summary
- Gina Chapman, a director of Entrada Therapeutics, Inc., acquired stock options on June 13, 2024.
- The options grant the right to buy 16,000 shares of common stock at an exercise price of $16.45.
- The options vest on the earlier of June 13, 2025 (one year after the grant date) or the Issuer's next annual meeting of stockholders.
- The options expire on June 13, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock option grants, which is a common practice. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider transactions.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- Shareholders may view this as a positive sign if they believe the director's increased stake aligns their interests with the company's success.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of the transaction: Gina Chapman acquired stock options. |
| 06/13/2024 | Date the stock options were granted. |
| 06/13/2025 | Date the stock options vest, or the date of the next annual meeting of stockholders, whichever is earlier. |
| 06/13/2034 | Expiration date of the stock options. |
| 06/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.